Kristen Ambrose sold $633K of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 11 2025, disclosed Feb 12 2025, 1 day later.

Value, as filed

$633K

1,376 sh × $459.83

Executed

Feb 11 2025

the trade date, as filed

Disclosed

Feb 12 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KA Kristen Ambrose SVP & Chief Accounting Officer profile →

Kristen Ambrose (SVP & Chief Accounting Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $1.1M of VRTX (2,195 sh across 2 lots, as filed), executed Feb 17.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 90 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kristen Ambrose in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $173K
357 sh × $483.36
Exec Feb 26
Filed Mar 2 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $108K
223 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.1M
2,195 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $634K
1,376 sh × $460.43
Exec Feb 11
Filed Feb 12 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $425K
884 sh × $480.95
Exec Feb 25 2025
Filed Feb 26 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $305K
671 sh × $455.06
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET